Wassihun Wedajo Aragaw

PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme Inhibitor.

Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.

Reinvestigation of the structure-activity relationships of isoniazid.

Potency boost of a dihydrofolate reductase inhibitor by multienzyme FH-dependent reduction.

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.

Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.

Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus.

A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study.

Structural and Mechanistic Insights into Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor.

Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.

Synthesis and Characterization of Phenylalanine Amides Active against and Other Mycobacteria.

Characterization of Resistance to Linezolid in Mycobacterium abscessus.

Pharmacological validation of dihydrofolate reductase as a drug target in .

A pairwise approach to revitalize β-lactams for the treatment of TB.

Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of .

Durlobactam to boost the clinical utility of standard of care β-lactams against lung disease.